{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:08:04Z","timestamp":1790096884545,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2023-00264541"],"award-info":[{"award-number":["RS-2023-00264541"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.virusres.2026.199793","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:50:08Z","timestamp":1787295008000},"page":"199793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An inactivated human adenovirus type 55 vaccine attenuates pulmonary pathology in a non-human primate challenge model"],"prefix":"10.1016","volume":"372","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2670-165X","authenticated-orcid":false,"given":"Jun Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-ah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Im","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8132-3044","authenticated-orcid":false,"given":"Chanmi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1314-7952","authenticated-orcid":false,"given":"Minkyung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ho","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Joo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1582-303X","authenticated-orcid":false,"given":"Soon-Hwan","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8474-576X","authenticated-orcid":false,"given":"Won-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manki","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hwan","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0001","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1378\/chest.13-1186","article-title":"Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia","volume":"145","author":"Cao","year":"2014","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.virusres.2026.199793_bib0002","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.21037\/qims-20-531","article-title":"Chest lesion CT radiological features and quantitative analysis in RT-PCR turned negative and clinical symptoms resolved COVID-19 patients","volume":"10","author":"Du","year":"2020","journal-title":"Quant. ImAging Med. Surg."},{"issue":"10","key":"10.1016\/j.virusres.2026.199793_bib0003","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4161\/hv.29594","article-title":"Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?","volume":"10","author":"Fausther-Bovendo","year":"2014","journal-title":"Hum. Vaccin. ImmunOther"},{"key":"10.1016\/j.virusres.2026.199793_bib0004","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.virol.2018.03.002","article-title":"Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity","volume":"518","author":"Feng","year":"2018","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.virusres.2026.199793_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00747-20","article-title":"Human Desmoglein-2 and Human CD46 mediate Human Adenovirus type 55 infection, but Human Desmoglein-2 plays the major roles","volume":"94","author":"Feng","year":"2020","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2026.199793_bib0006","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.ymthe.2025.12.027","article-title":"A replication-incompetent adenovirus type 55 vaccine induces broad and durable protective immunity against pathogenic adenoviruses","volume":"34","author":"Feng","year":"2026","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.virusres.2026.199793_bib0007","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/oxfordjournals.aje.a121632","article-title":"Occurrence of respiratory illness due to an atypical strain of adenovirus type 11 during a large outbreak in Spanish military recruits","volume":"99","author":"Hierholzer","year":"1974","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.virusres.2026.199793_bib0008","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JCM.01928-09","article-title":"Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP","volume":"48","author":"Kajon","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.virusres.2026.199793_bib0009","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2024.39.e38","article-title":"Prevalence and burden of Human Adenovirus-associated acute Respiratory illness in the Republic of Korea Military, 2013 to 2022","volume":"39","author":"Kim","year":"2024","journal-title":"J. Korean Med. Sci."},{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0010","article-title":"Systems serology-based comparison of humoral immune responses induced by liposome or aluminum hydroxide adjuvanted SARS-CoV-2 spike protein","volume":"15","author":"Kim","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0011","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3904\/kjim.2019.092","article-title":"Ongoing outbreak of human adenovirus-associated acute respiratory illness in the Republic of Korea military, 2013 to 2018","volume":"36","author":"Ko","year":"2021","journal-title":"Korean J. Intern. Med."},{"issue":"11","key":"10.1016\/j.virusres.2026.199793_bib0012","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3201\/eid2211.160728","article-title":"Severe pneumonia associated with Adenovirus type 55 infection, France, 2014","volume":"22","author":"Lafolie","year":"2016","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00998-24","article-title":"Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults","volume":"10","author":"Lee","year":"2025","journal-title":"mSphere"},{"issue":"3","key":"10.1016\/j.virusres.2026.199793_bib0014","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"issue":"16","key":"10.1016\/j.virusres.2026.199793_bib0015","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.vaccine.2018.02.050","article-title":"A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55","volume":"36","author":"Liu","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0016","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2307513","article-title":"Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews","volume":"13","author":"Liu","year":"2024","journal-title":"Emerg. Microbes. Infect."},{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0017","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12879-020-05258-2","article-title":"An outbreak of acute respiratory infection at a training base in Beijing, China due to human adenovirus type B55","volume":"20","author":"Lu","year":"2020","journal-title":"BMC. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2026.199793_bib0018","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1055\/s-0041-1733802","article-title":"Adenovirus: epidemiology, global spread of novel types, and approach to treatment","volume":"42","author":"Lynch","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.virusres.2026.199793_bib0019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcv.2016.03.002","article-title":"Outbreak of adenovirus type 55 infection in Israel","volume":"78","author":"Salama","year":"2016","journal-title":"J. Clin. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12985-024-02491-y","article-title":"Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice","volume":"21","author":"Seo","year":"2024","journal-title":"Virol. J."},{"issue":"2","key":"10.1016\/j.virusres.2026.199793_bib0021","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1093\/infdis\/jiaf542","article-title":"Establishment of a Cynomolgus Macaque model for Human Adenovirus type 55-induced Respiratory disease","volume":"233","author":"Seo","year":"2026","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virusres.2026.199793_bib0022","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00430-019-00645-2","article-title":"Human adenovirus binding to host cell receptors: a structural view","volume":"209","author":"Stasiak","year":"2020","journal-title":"Med. Microbiol. Immunol."},{"issue":"11","key":"10.1016\/j.virusres.2026.199793_bib0023","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"Sumida","year":"2005","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.virusres.2026.199793_bib0024","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.virusres.2011.06.017","article-title":"Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon","volume":"160","author":"Tian","year":"2011","journal-title":"Virus. Res."},{"key":"10.1016\/j.virusres.2026.199793_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2018.04.001","article-title":"A tetravalent vaccine comprising hexon-chimeric adenoviruses elicits balanced protective immunity against human adenovirus types 3, 7, 14 and 55","volume":"154","author":"Tian","year":"2018","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085432","article-title":"Innate functions of immunoglobulin M lessen liver gene transfer with helper-dependent adenovirus","volume":"9","author":"Unzu","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.virusres.2026.199793_bib0027","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fimmu.2019.00548","article-title":"Fc-mediated antibody effector functions during Respiratory syncytial virus infection and disease","volume":"10","author":"van Erp","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.virusres.2026.199793_bib0028","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/JCM.01694-09","article-title":"Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen","volume":"48","author":"Walsh","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0029","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4049\/jimmunol.116.1.19","article-title":"Antigenic determinants of adenovirus capsids. I. Measurement of antibody cross-reactivity","volume":"116","author":"Willcox","year":"1976","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000149211","article-title":"Immunological relationship among adenoviruses of humans, simians, and nonprimates as determined by the neutralization test","volume":"15","author":"Willimzik","year":"1981","journal-title":"Intervirology"},{"issue":"24","key":"10.1016\/j.virusres.2026.199793_bib0031","doi-asserted-by":"crossref","first-page":"12775","DOI":"10.1128\/JVI.76.24.12775-12782.2002","article-title":"Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon","volume":"76","author":"Wu","year":"2002","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0032","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/s12879-018-3520-z","article-title":"Case-control study of the epidemiological and clinical features of human adenovirus 55 and human adenovirus 7 infection in children with acute lower respiratory tract infections in Beijing, China, 2008-2013","volume":"18","author":"Xu","year":"2018","journal-title":"BMC. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2026.199793_bib0033","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3201\/eid2306.161848","article-title":"Febrile Respiratory illness associated with Human Adenovirus type 55 in South Korea military, 2014-2016","volume":"23","author":"Yoo","year":"2017","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2026.199793_bib0034","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcb.22328","article-title":"The influence of innate and pre-existing immunity on adenovirus therapy","volume":"108","author":"Zaiss","year":"2009","journal-title":"J. Cell Biochem."},{"issue":"6","key":"10.1016\/j.virusres.2026.199793_bib0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41577-022-00813-1","article-title":"Beyond neutralization: fc-dependent antibody effector functions in SARS-CoV-2 infection","volume":"23","author":"Zhang","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"22","key":"10.1016\/j.virusres.2026.199793_bib0036","doi-asserted-by":"crossref","first-page":"12441","DOI":"10.1128\/JVI.02225-12","article-title":"Genome sequence of human adenovirus type 55, a re-emergent acute respiratory disease pathogen in China","volume":"86","author":"Zhang","year":"2012","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2026.199793_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01090-23","article-title":"Higher affinities of fibers with cell receptors increase the infection capacity and virulence of human adenovirus type 7 and type 55 compared to type 3","volume":"12","author":"Zhang","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"5","key":"10.1016\/j.virusres.2026.199793_bib0038","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00209-23","article-title":"Generation of Human embryonic stem cell-derived lung organoids for modeling infection and replication differences between Human Adenovirus types 3 and 55 and evaluating potential antiviral drugs","volume":"97","author":"Zhao","year":"2023","journal-title":"J. Virol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:13:27Z","timestamp":1790093607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"alternative-id":["S0168170226001127"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199793","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An inactivated human adenovirus type 55 vaccine attenuates pulmonary pathology in a non-human primate challenge model","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199793"}}